Search results
Oct 10, 2024 · Further, THQ has also outperformed The Health Care Select Sector SPDR ETF . This would seem to be the fund's leverage at play plus portfolio positioning, helping to drive better overall total ...
- THQ: Investing In A Healthy Future - Seeking Alpha
The THQ fund is currently trading at a discount of -13.75%...
- THQ: Still The Best Of The Tekla Suite - Seeking Alpha
Moreover, comparing 5-year returns to the funds' stated...
- THQ: Investing In A Healthy Future - Seeking Alpha
Sep 30, 2024 · Learn more about the abrdn Healthcare Opportunities (THQ: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help ...
The THQ fund is currently trading at a discount of -13.75% as of market close on January 19. That is close to the widest discount that the fund has seen in the past five years.
Find the latest Abrdn Healthcare Opportunities Fund (THQ) stock quote, history, news and other vital information to help you with your stock trading and investing.
About THQ. Abrdn Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by abrdn Inc. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles.
- $1.89 (8.56%)
- 913.21M
- Sep 23, 2024
- 41.34M
Sep 6, 2023 · Moreover, comparing 5-year returns to the funds' stated distribution yields, the THQ fund is the only Tekla fund where 5-year returns (6.7%) are comparable to the distribution yield (7.2%).
People also ask
Should you invest in THQ & Cohen & Steers Infrastructure Fund?
Is abrdn Healthcare Opportunities Fund (THQ) a good investment?
What does THQ stand for?
How does THQ invest?
What is THQ and how does it function?
Should I invest in a closed-end healthcare fund?
Oct 12, 2024 · The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics.
